News Release

Home
10/02/17
Industry Leaders Gather at Medidata NEXT Global 2017 to Discuss How Technology is Transforming Clinical Research

Medidata Hosts Forum on Latest in Clinical Trial Innovation to Accelerate the Delivery of Life Changing Patient Treatments

NEW YORK--(BUSINESS WIRE)--Oct. 2, 2017-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced that Medidata NEXT Global will take place in New York, at Spring Studios from November 8-10. The event will host 89 sessions and eight keynotes, with over half led by Medidata customers and CRO partners; including senior executives and experts from Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Memorial Sloan Kettering, Worldwide Clinical Trials, Accenture and more. Medidata NEXT Global is the centerpiece of the largest annual event series of its kind, attracting over 3,000 attendees across events in Basel, Berlin, London, New York, Seoul, Shanghai and Tokyo.

Medidata NEXT is where science meets technology meets the future, with interactive, hands-on learning opportunities to design, execute, manage and monitor the next generation of clinical research. The event will attract industry leaders in drug and device development, clinical operations, data management, biostatistics and digital medicine innovation for networking and collaboration.

Medidata NEXT Global’s keynotes and presentations will feature visionaries who are propelling the industry forward, such as Emory University’s Frances Winship Walters Professor of Pediatrics & Biochemical Pharmacology Director, Raymond Schinazi, PhD, whose pioneering work on antiviral treatments has transformed HIV and hepatitis C into manageable or curative conditions. The gathering will also spotlight community leaders facilitating new techniques for disease awareness, including T.J. Sharpe, patient advocate and stage IV melanoma fighter, as well as Nancy Frates, mother of ALS patient, Pete Frates, whose family championed the historic 2014 ALS Ice Bucket Challenge.

During the event, thought-provoking breakout sessions will also highlight cutting-edge innovation within each phase of the clinical development lifecycle, covering areas like study planning, site support, study conduct, patient engagement, and risk-based monitoring. Experience firsthand how technology such as Medidata Strategic Monitoring is enabling compliance with the implementation of ICH E6 guidelines during an expert customer panel featuring Celgene, Bristol-Myers Squibb and Karyopharm. Sessions include:

How Big Data and Analytics are Changing Clinical Trials
Speaker: David Lee, Medidata, Chief Data Officer
Learn how to improve operational and scientific decision making for clinical trials by harnessing Medidata's unique data sources and analytics. This presentation will highlight how new data science solutions including predictive models, machine learning and genomic analysis can improve your clinical trials.

PARADE: Pharma's First Apple ResearchKit Study
Speaker: Bill Lander, GSK, Director of Innovation and Clinical Platforms
GSK Launched PARADE, the industry’s first implementation of Apple’s ResearchKit™ in 2016. In this presentation, Bill Lander will walk through the details of the set-up and implementation of this project and key findings.

“Medidata NEXT Global is the ideal environment to see how our integrated platform pushes scientific innovation, advances research programs, and ultimately drives better clinical outcomes that change lives,” said Glen de Vries, Medidata president and co-founder. “At our NEXT Global event, we'll take a deep-dive into how our intelligent, unified platform is the key to simplifying complex processes that touch sponsors, CROs, sites and patients — bringing together technology, data, processes and people.”

The NEXT Innovation Lounge will also feature a digital showcase presented by healthcare tech innovator, HITLAB.

Register today to network with industry peers and engage in discussions on how technology is redefining clinical research, thus accelerating hope for patients worldwide.

About Medidata

Medidata is reinventing global drug and medical device development by creating the industry's leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including over 850 global pharmaceutical companies, biotech, diagnostic and device firms, leading academic medical centers, and contract research organizations.

The Medidata Clinical Cloud® brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The Medidata Clinical Cloud is the primary technology solution powering clinical trials for 18 of the world's top 25 global pharmaceutical companies and is used by 18 of the top 25 medical device developers—from study design and planning through execution, management and reporting.

Source: Medidata

Medidata
Investors:

Anthony D’Amico, 732-767-4331
adamico@mdsol.com
or
Media:
Erik Snider, 646-362-2997
esnider@mdsol.com

Investor Contact

Anthony D'Amico
Senior Director, Investor Relations
+1 732 767 4331
adamico@mdsol.com